• This is a political forum that is non-biased/non-partisan and treats every person's position on topics equally. This debate forum is not aligned to any political party. In today's politics, many ideas are split between and even within all the political parties. Often we find ourselves agreeing on one platform but some topics break our mold. We are here to discuss them in a civil political debate. If this is your first visit to our political forums, be sure to check out the RULES. Registering for debate politics is necessary before posting. Register today to participate - it's free!

Donald Trump has a 7-point healthcare plan

cabse5 said:
The GOP actions is noted. I have this evidence pharmaceutical companies were given inducements to back ACA when it was first proposed by the democratic congress.Forbes Welcome
Click to expand...

Link doesn't work for me because I use ad-blocking software. Try again.

However, I will note that the reason why Medicare can't negotiate drug prices is because the repubs passed a law forbidding it years before ACA was even thought up.

But let me know if you can find a quote from a dem arguing that letting Medicare negotiate drug prices would be a bad thing.
 
"Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between “$10 billion and $35 billion in additional profits over the next decade,” a new analysis shows.

The health law, which will bring millions of uninsured Americans health benefits beginning in January 2014, will be a critical boon to pharmaceutical industry balance sheets, increasing revenue by one-third by the end of the decade, according to a new report from research and consulting firm GlobalData of London. That means the U.S. pharmaceutical industry’s market value will mushroom by 33 percent to $476 billion in 2020 from $359 billion last year.

The increase in sales and profits comes amid a wave of expiring patents on some of the industry’s most popular brand name drugs such as Lipitor from Pfizer PFE -0.60% (PFE), the blood thinner Plavix sold by Bristol-Myers Squibb BMY -0.45% (BMY), the diabetes drug Actos from Eli Lilly (LLY) and Takeda Pharmaceuticals as well as various cholesterol treatments sold by Abbott Laboratories ABT +0.93% (ABT) and its recently spun off proprietary business AbbVie ABBV +0.39% (ABBV). In large part because of competition from cheaper generic drugs, a report last year from IMS Health, for example, said pharmaceutical manufacturers will see “minimal growth in their branded products through 2016.”

I have this 'non-cited' example of ACA demanding the higher priced drug: My best friend is an epileptic and takes Tegretol every day to control his seizures. Whenever he asks for a refill of his Tegretol, his pharmacy tells him there is a generic medication that is much cheaper. This notification process takes an extra 2 days for the refill. Numerous times he's told his pharmacy he would be fine with the generic but his ACA medication program will only refill the Tegretol.
 
Last edited:
cabse5 said:
"Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between “$10 billion and $35 billion in additional profits over the next decade,” a new analysis shows.

The health law, which will bring millions of uninsured Americans health benefits beginning in January 2014, will be a critical boon to pharmaceutical industry balance sheets, increasing revenue by one-third by the end of the decade, according to a new report from research and consulting firm GlobalData of London. That means the U.S. pharmaceutical industry’s market value will mushroom by 33 percent to $476 billion in 2020 from $359 billion last year.

The increase in sales and profits comes amid a wave of expiring patents on some of the industry’s most popular brand name drugs such as Lipitor from Pfizer PFE -0.60% (PFE), the blood thinner Plavix sold by Bristol-Myers Squibb BMY -0.45% (BMY), the diabetes drug Actos from Eli Lilly (LLY) and Takeda Pharmaceuticals as well as various cholesterol treatments sold by Abbott Laboratories ABT +0.93% (ABT) and its recently spun off proprietary business AbbVie ABBV +0.39% (ABBV). In large part because of competition from cheaper generic drugs, a report last year from IMS Health, for example, said pharmaceutical manufacturers will see “minimal growth in their branded products through 2016.”
Click to expand...

I don't any quotes from any dem politicians. And it says nothing about medicare negotiating drug prices

Stop wasting your time.
 
So you refuse to see incentives were put into place by proponents of ACA (surely not GOPS) for pharmaceutical drug companies and insurance companies to lobby for ACA while it was still being debated in 2010?
Maybe that doesn't matter to you?
 
Last edited:
cabse5 said:
So you refuse to see incentives were put into place for pharmaceutical drug companies and insurance companies for these companies to lobby for ACA while it was still being debated in 2010?
Maybe that doesn't matter to you?
Click to expand...

Please provide a quote from that article where a democrat says that letting Medicare negotiate drug prices is a bad thing.

Otherwise, stop wasting my time.
 
faithful_servant said:
I'd like to see a law passed that made employer provided health insurance illegal. Sounds kind of weird at first, but hear me out... We would still allow employers to pay a person's premiums as a tax deductible expense, but the policy stays with the employee and doesn't disappear when they change jobs. Provides complete portability between jobs, minimizes the impact of being denied coverage for pre-existing conditions just because you changed jobs and gives the individual control over what they want to pay for.
Click to expand...

Won't happen. Insurance companies took over where the Mafia left off. LOL.
 
sangha said:
Please provide a quote from that article where a democrat says that letting Medicare negotiate drug prices is a bad thing.

Otherwise, stop wasting my time.
Click to expand...
ACA evoked the high prices and the GOP continued these high prices. Both parties are to blame. Don't like the anecdote?
 
Last edited:
cabse5 said:
ACA evoked the high prices and the GOP continued these high prices. Both parties are to blame.
Click to expand...
Please provide a quote from that article where a democrat says that letting Medicare negotiate drug prices is a bad thing.

Otherwise, stop wasting my time.
 
ObamacareFail said:
The one and only thing that can reduce healthcare costs is to make providing healthcare competitive again. Government needs to stop over-regulating it and health insurance. Remove many of the state and federal government regulations that drive the cost up.
Click to expand...

No, that's not the one and only thing. There are many reason why costs are so high.
 
You must log in or register to reply here.
Back
Top Bottom